Form 4 for SUPN SUPERNUS PHARMACEUTICALS, INC.
Accepted 2026-03-10 00:00:00 ET · period of report 2026-03-06 · accession 0001539937-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-10 | 2026-03-06 | SUPN | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $0.00 | +38.6K | 1.25M | +3% | $0 |
| D | 2026-03-10 | 2026-03-06 | SUPN | Khattar Jack A. | Pres, CEO, Dir | F - Tax | $54.73 | -16.6K | 1.23M | -1% | -$907.1K |
| D | 2026-03-10 | 2026-03-06 | SUPN | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $0.00 | -38.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-06 | M | A | 38,640 | $0.00 | 1,245,218 | D | — | — | |
| 2 | Common | Common Stock | 2026-03-06 | F | D | 16,574 | $54.73 | 1,228,644 | D | — | — | |
| 3 | Derivative | Performance Share Unit | 2026-03-06 | M | D | 38,640 | $0.00 | 0 | D | $0.00 · — to — | 38,640 Common Stock | (F2) On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024. |